Centene Co. (NYSE:CNC – Free Report) – Stock analysts at Zacks Research lowered their FY2024 earnings per share (EPS) estimates for Centene in a research note issued to investors on Wednesday, September 11th. Zacks Research analyst K. Dey now anticipates that the company will post earnings of $6.82 per share for the year, down from their prior estimate of $6.84. The consensus estimate for Centene’s current full-year earnings is $6.82 per share. Zacks Research also issued estimates for Centene’s Q4 2024 earnings at $0.75 EPS, Q1 2025 earnings at $2.72 EPS, Q4 2025 earnings at $1.00 EPS and Q1 2026 earnings at $3.00 EPS.
Centene (NYSE:CNC – Get Free Report) last issued its quarterly earnings data on Friday, July 26th. The company reported $2.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.02). The company had revenue of $39.84 billion for the quarter, compared to analysts’ expectations of $36.83 billion. Centene had a net margin of 1.79% and a return on equity of 14.45%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the company earned $2.10 earnings per share.
Get Our Latest Analysis on Centene
Centene Trading Up 0.7 %
CNC opened at $75.35 on Friday. Centene has a one year low of $63.45 and a one year high of $81.42. The stock has a market cap of $39.64 billion, a price-to-earnings ratio of 14.98, a P/E/G ratio of 0.99 and a beta of 0.48. The stock’s 50 day moving average price is $73.57 and its 200-day moving average price is $73.56. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.17 and a current ratio of 1.17.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. Rise Advisors LLC purchased a new position in Centene during the first quarter worth approximately $25,000. WR Wealth Planners LLC raised its holdings in shares of Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after purchasing an additional 137 shares in the last quarter. Chris Bulman Inc bought a new stake in shares of Centene in the 2nd quarter worth approximately $33,000. Riverview Trust Co lifted its position in shares of Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after acquiring an additional 320 shares in the last quarter. Finally, Neo Ivy Capital Management acquired a new position in Centene in the 4th quarter valued at approximately $40,000. 93.63% of the stock is owned by hedge funds and other institutional investors.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
- Five stocks we like better than Centene
- What is the Shanghai Stock Exchange Composite Index?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- How to Use the MarketBeat Dividend Calculator
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.